Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) that target central nervous system disorders. Its protected amine group allows for selective reactions in multi-step organic syntheses, making it valuable in constructing complex drug molecules. Commonly employed in the preparation of nootropic agents and other neurologically active substances due to its pyrrolidine backbone, which is known to enhance bioavailability and receptor binding. Also utilized in research settings for generating compound libraries in medicinal chemistry through solid-phase and solution-phase peptide-like synthesis.